ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $329 | -99.9% | 7,080 | -4.8% | 0.03% | -13.2% |
| Q3 2022 | $386,000 | -16.6% | 7,440 | +20.2% | 0.04% | -25.5% |
| Q4 2021 | $463,000 | +59.7% | 6,190 | +103.7% | 0.05% | +6.2% |
| Q1 2019 | $290,000 | -37.4% | 3,039 | -43.8% | 0.05% | -25.0% |
| Q3 2018 | $463,000 | +8.9% | 5,412 | -25.2% | 0.06% | -14.7% |
| Q4 2017 | $425,000 | +105.3% | 7,240 | +2.6% | 0.08% | +33.9% |
| Q1 2016 | $207,000 | – | 7,055 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |